164 related articles for article (PubMed ID: 34148955)
1. Spontaneous Regression of Small Cell Lung Carcinoma and Associated Hemichorea.
Shibata K; Nishimura Y; Sakura H
Intern Med; 2021 Dec; 60(23):3817-3821. PubMed ID: 34148955
[TBL] [Abstract][Full Text] [Related]
2. CV2/CRMP5-antibody-related Paraneoplastic Optic Neuropathy Associated with Small-cell Lung Cancer.
Nakajima M; Uchibori A; Ogawa Y; Miyazaki T; Ichikawa Y; Kaneko K; Takahashi T; Nakashima I; Shiraishi H; Motomura M; Chiba A
Intern Med; 2018 Jun; 57(11):1645-1649. PubMed ID: 29321433
[TBL] [Abstract][Full Text] [Related]
3. Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies.
Honnorat J; Cartalat-Carel S; Ricard D; Camdessanche JP; Carpentier AF; Rogemond V; Chapuis F; Aguera M; Decullier E; Duchemin AM; Graus F; Antoine JC
J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):412-6. PubMed ID: 18931014
[TBL] [Abstract][Full Text] [Related]
4. [A case of paraneoplastic myelopathy associated with anti-CV2/CRMP5 antibodies with small-cell lung cancer].
Sato C; Kano T; Yabe I; Sasaki H
Rinsho Shinkeigaku; 2020 Aug; 60(8):560-564. PubMed ID: 32641628
[TBL] [Abstract][Full Text] [Related]
5. Paraneoplastic Choreoathetosis in a Patient with Small Cell Lung Carcinoma and Anti-CRMP5/CV2: A Case Report.
Aydin D; Somnier F; Lassen LH
Case Rep Neurol; 2016; 8(1):16-9. PubMed ID: 26889151
[TBL] [Abstract][Full Text] [Related]
6. [Neurologic paraneoplastic syndrome with anti-CV2/CRMP5 antibodies revealing a small cell lung cancer. Effectiveness of the lung cancer treatment].
Rosencher L; Maisonobe T; Lavole A; Milleron B; Ferroir JP
Rev Neurol (Paris); 2012 Apr; 168(4):371-4. PubMed ID: 22387203
[TBL] [Abstract][Full Text] [Related]
7. Predicting disability and mortality in CV2/CRMP5-IgG associated paraneoplastic neurologic disorders.
Uysal SP; Li Y; Thompson NR; Milinovich A; Abbatemarco JR; Cohen JA; Conway DS; Ontaneda D; Morren JA; Kunchok A
Ann Clin Transl Neurol; 2024 Mar; 11(3):710-718. PubMed ID: 38251800
[TBL] [Abstract][Full Text] [Related]
8. SOX1 antibodies in sera from patients with paraneoplastic neurological syndromes.
Stich O; Klages E; Bischler P; Jarius S; Rasiah C; Voltz R; Rauer S
Acta Neurol Scand; 2012 May; 125(5):326-31. PubMed ID: 21751968
[TBL] [Abstract][Full Text] [Related]
9. Anti-CV2/CRMP5 antibody-positive paraneoplastic neurological syndromes with chronic intestinal pseudo-obstruction in a small-cell lung cancer patient: a case report and literature review.
Yan J; Chen Z; Liang Y; Yang H; Cao L; Zhou Y; Zhao Y; Zhang Y
J Int Med Res; 2020 Dec; 48(12):300060520974466. PubMed ID: 33305627
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic striatal encephalitis and myelitis associated with anti-CV2/CRMP-5 antibodies in a patient with small cell lung cancer.
Dericioglu N; Gocmen R; Tan E
Clin Neurol Neurosurg; 2018 Jul; 170():117-119. PubMed ID: 29777943
[No Abstract] [Full Text] [Related]
11. [Paraneoplastic chorea and behavioral disorders in a patient with anti-CV2/CRMP5 antibodies and two different tumors].
Ritzenthaler T; Verret JM; Honnorat J
Rev Neurol (Paris); 2010 Jan; 166(1):90-5. PubMed ID: 19497605
[TBL] [Abstract][Full Text] [Related]
12. Antibody repertoire in paraneoplastic cerebellar degeneration and small cell lung cancer.
Sabater L; Höftberger R; Boronat A; Saiz A; Dalmau J; Graus F
PLoS One; 2013; 8(3):e60438. PubMed ID: 23536908
[TBL] [Abstract][Full Text] [Related]
13. Anti-CV2/CRMP5 Paraneoplastic Chorea Effectively Managed with Intravenous Amantadine.
Ha J; Na BS; Ahn JH; Kim M; Kim JW; Lee JH; Cho JW; Kim JS; Youn J
Tremor Other Hyperkinet Mov (N Y); 2019; 9():. PubMed ID: 31656691
[TBL] [Abstract][Full Text] [Related]
14. Anti-CV2/CRMP5 antibody-associated hemorrhagic leukoencephalomyelitis treated with steroids, intravenous immunoglobulin, plasmapheresis, and cyclophosphamide.
Chu L; Clift F
Mult Scler Relat Disord; 2020 May; 40():101964. PubMed ID: 32044694
[TBL] [Abstract][Full Text] [Related]
15. Anti-SOX1 Antibody-positive Small-cell Lung Cancer That Triggered Opsoclonus.
Chiko Y; Sugisaki Y; Miyoshi K; Morichika D; Beika Y; Taniguchi A; Ichihara E; Okada T
Intern Med; 2023 Mar; 62(6):881-884. PubMed ID: 35989271
[TBL] [Abstract][Full Text] [Related]
16. Small cell lung cancer and progressive retinopathy.
Morita M; Fukuhara T; Takahashi H; Maemondo M
BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25422332
[TBL] [Abstract][Full Text] [Related]
17. An overview on CV2/CRMP5 antibody-associated paraneoplastic neurological syndromes.
Wang S; Hou H; Tang Y; Zhang S; Wang G; Guo Z; Zhu L; Wu J
Neural Regen Res; 2023 Nov; 18(11):2357-2364. PubMed ID: 37282453
[TBL] [Abstract][Full Text] [Related]
18. CRMP5 antibodies in patients with small-cell lung cancer or thymoma.
Monstad SE; Drivsholm L; Skeie GO; Aarseth JH; Vedeler CA
Cancer Immunol Immunother; 2008 Feb; 57(2):227-32. PubMed ID: 17657489
[TBL] [Abstract][Full Text] [Related]
19. Paraneoplastic Syndrome Presenting Combined Central and Peripheral Demyelination Associated with Anti-CV2/CRMP5 and Anti-NF186 Antibodies: A Case Report.
Liu B; Zhou L; Zheng Y; Sun C; Lin J
Brain Sci; 2023 Feb; 13(3):. PubMed ID: 36979184
[TBL] [Abstract][Full Text] [Related]
20. [A case of anti-SRY-Related HMG-Box Gene 1 (SOX1) antibody-positive chorea].
Yamagishi T; Inoue K; Ouchi H; Shibano K; Hara K
Rinsho Shinkeigaku; 2020 Dec; 60(12):852-856. PubMed ID: 33229831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
